"Midodrine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An ethanolamine derivative that is an adrenergic alpha-1 agonist. It is used as a vasoconstrictor agent in the treatment of HYPOTENSION.
Descriptor ID |
D008879
|
MeSH Number(s) |
D02.033.100.291.480 D02.092.063.291.480
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Midodrine".
Below are MeSH descriptors whose meaning is more specific than "Midodrine".
This graph shows the total number of publications written about "Midodrine" by people in this website by year, and whether "Midodrine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2008 | 1 | 0 | 1 |
2009 | 0 | 1 | 1 |
2016 | 0 | 1 | 1 |
2017 | 1 | 1 | 2 |
2018 | 1 | 0 | 1 |
2019 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Midodrine" by people in Profiles.
-
Midodrine and albumin in decompensated cirrhosis: Down but not out…. J Hepatol. 2019 04; 70(4):811.
-
Trends in Use of Midodrine in the ICU: A Single-Center Retrospective Case Series. Crit Care Med. 2018 07; 46(7):e628-e633.
-
Hepatorenal syndrome: the clinical impact of vasoactive therapy. Expert Rev Gastroenterol Hepatol. 2018 Feb; 12(2):173-188.
-
Fludrocortisone Is Associated With a Higher Risk of All-Cause Hospitalizations Compared With Midodrine in Patients With Orthostatic Hypotension. J Am Heart Assoc. 2017 Oct 12; 6(10).
-
Comparative efficacy of pharmacological strategies for management of type 1 hepatorenal syndrome: a systematic review and network meta-analysis. Lancet Gastroenterol Hepatol. 2017 02; 2(2):94-102.
-
Chronic hypotension and modulation of autonomic cardiovascular regulation. Hypertens Res. 2009 Nov; 32(11):931-3.
-
Midodrine versus albumin in the prevention of paracentesis-induced circulatory dysfunction in cirrhotics: a randomized pilot study. Am J Gastroenterol. 2008 Jun; 103(6):1399-405.